Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
27 01 2021
Historique:
pubmed: 1 7 2020
medline: 27 7 2021
entrez: 30 6 2020
Statut: ppublish

Résumé

This paper belongs to a series of recommendation documents for participation in leisure-time physical activity and competitive sports by the European Association of Preventive Cardiology (EAPC). Together with an accompanying paper on supraventricular arrhythmias, this second text deals specifically with those participants in whom some form of ventricular rhythm disorder is documented, who are diagnosed with an inherited arrhythmogenic condition, and/or who have an implanted pacemaker or cardioverter defibrillator. A companion text on recommendations in athletes with supraventricular arrhythmias is published in the European Journal of Preventive Cardiology. Since both texts focus on arrhythmias, they are the result of a collaboration between EAPC and the European Heart Rhythm Association (EHRA). The documents provide a framework for evaluating eligibility to perform sports, based on three elements, i.e. the prognostic risk of the arrhythmias when performing sports, the symptomatic impact of arrhythmias while performing sports, and the potential progression of underlying structural problems as the result of sports.

Identifiants

pubmed: 32596731
pii: 5864077
doi: 10.1093/europace/euaa106
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-148

Investigateurs

Frank R Heinzel (FR)
Christian Veltmann (C)
Katja E Odening (KE)
Leif-Hendrik Boldt (LH)
Wim Anné (W)
Carlo Napolitano (C)
Constantinos H Davos (CH)
Massimo Piepoli (M)
Alessandro Biffi (A)
Frank van Buuren (F)
Nikolaos Dagres (N)
Serge Boveda (S)
Kevin Vernooy (K)
Zbigniew Kalarus (Z)
Gulmira Kudaiberdieva (G)
Georges H Mairesse (GH)
Valentina Kutyifa (V)
Thomas Deneke (T)
Jesper Hastrup Svendsen (JH)
Vassil B Traykov (VB)
Arthur Wilde (A)
Frank R Heinzel (FR)

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Hein Heidbuchel (H)

Department of Cardiology, University Hospital Antwerp, University Antwerp, Wilrijkstraat 10, 2650 Antwerp, Belgium.

Elena Arbelo (E)

Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Flavio D'Ascenzi (F)

Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Mats Borjesson (M)

Centre for Health and Performance (CHP), Department of Food, Nutrition and Sport Sciences, Gothenburg University, Sweden.
Department of Neuroscience and Physiology, Gothenburg University, Gothenburg, Sweden.

Serge Boveda (S)

Cardiology Department, Clinique Pasteur, 45 Avenue de Lombez, 31076 Toulouse, France.

Silvia Castelletti (S)

Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin, Laboratory of Cardiovascular Genetics, Milan, Italy.

Hielko Miljoen (H)

Department of Cardiology, University Hospital Antwerp, University Antwerp, Wilrijkstraat 10, 2650 Antwerp, Belgium.

Lluis Mont (L)

Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Josef Niebauer (J)

Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg, Salzburg, Austria.

Michael Papadakis (M)

Cardiology Clinical Academic Group, St. George's University of London, London, UK.
St. George's University Hospitals NHS Foundation Trust, London, UK.

Antonio Pelliccia (A)

National Institute of Sports Medicine, Italian National Olympic Committee, Via dei Campi Sportivi 46, Rome, Italy.

Johan Saenen (J)

Department of Cardiology, University Hospital Antwerp, University Antwerp, Wilrijkstraat 10, 2650 Antwerp, Belgium.

María Sanz de la Garza (M)

Cardiovascular Institute, Hospital Clínic, Barcelona, Spain.

Peter J Schwartz (PJ)

Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin, Laboratory of Cardiovascular Genetics, Milan, Italy.

Sanjay Sharma (S)

Cardiology Clinical Academic Group, St. George's University of London, London, UK.
St. George's University Hospitals NHS Foundation Trust, London, UK.

Katja Zeppenfeld (K)

Department of Cardiology, Leiden University Medical Centre, Leiden, the Netherlands.

Domenico Corrado (D)

Department of Cardiology, University of Padova, Padova, Italy.
Department of Pathology, University of Padova, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH